"In a study published on 9 August 2025.. Emily Rayens, PhD, MPH, of Kaiser Permanente Southern California in Pasadena, and colleagues, matched 102,766 vaccinated patients (recombinant herpes zoster vaccine, Shingrix) with 411,064 unvaccinated patients based on age, sex, race/ethnicity, and index date. Patients received two doses of the vaccine 4 weeks to 6 months apart from April 2018 to December 2020. The average follow-up time was 2.5 years.
The researchers adjusted for factors such as history of herpes zoster, healthcare utilization patterns, and prior vaccination with the live shingles virus.
- Vaccinated individuals had a 72.9% lower risk of herpes zoster ophthalmicus.
- Vaccinated individuals had an 83.7% lower risk of postherpetic neuralgia.
- Vaccinated individuals had a 28% lower risk of hospitalization for acute myocardial infarction.
- Vaccinated individuals had a 42.5% lower risk of hospitalization for stroke."
My thoughts: I'm blown away by the effect sizes here. Flu vaccine has similar heart-protective effects.
Related research:
DAICStudy: Shingles Vaccine May Lower Heart Attack, Shingles RiskAug. 28, 2025 — A new global systematic literature review and meta-analysis has shown that herpes zoster vaccination, used to prevent shingles, is associated with a statistically significant lower risk of heart attack and stroke. The study is the first global systematic literature review and meta-analysis to comprehensively assess the evidence regarding an…dicardiology.com
